Medical research

• α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa (13 Aug 2022)
  
• A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery (07 Aug 2022)
  
• Exploring cannabinoid bioavailability in the medical cannabis industry (25 Jul 2022)